Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qinhuangdao Dahui Pharmaceutical is a specialized pharmaceutical manufacturer based in Qinhuangdao, China, focusing on the production of high-quality Active Pharmaceutical Ingredients (APIs) and intermediates. The company is a leading global supplier of the L-Carnitine series, including L-Carnitine base, L-Carnitine tartrate, and Acetyl-L-Carnitine hydrochloride. Their products are widely utilized in the pharmaceutical, nutraceutical, and animal nutrition sectors to address metabolic and energy-related health needs. Qinhuangdao Dahui operates advanced manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards. By maintaining a strong emphasis on research and quality control, the company supports a diverse international clientele across Europe, North America, and Asia. Their business model encompasses both independent product sales and contract manufacturing services for the global life sciences industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qinhuangdao Dahui.